Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Attached to antibody or antibody fragment or immunoglobulin;...
Reexamination Certificate
2008-04-30
2010-11-02
Yu, Misook (Department: 1642)
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Attached to antibody or antibody fragment or immunoglobulin;...
C424S001110, C424S001290, C424S001810, C530S387100
Reexamination Certificate
active
07824660
ABSTRACT:
The present invention provides a novel approach to cancer therapy and diagnostics that utilizes nanotubes and other similar nanostructures as both an indirect source of radiation therapy (BNCT), and as delivery vehicles for other types of radio- and chemo-therapeutic materials, as well as imaging agents for diagnostic purposes.
REFERENCES:
Hawthorne et al. (Journal of Neuro-Oncolgy 2003; 62: 33-45.
Peer et al, “Nanocarriers as an Emerging Platform for Cancer Therapy”, Nature Nanotechnology, 2 (2007), pp. 751-760.
Beger Richard
Birls Alex
Buzatu Dan A.
Darsey Jerry A.
Heinze Tom
Novak Druce & Quigg LLP
Yu Misook
LandOfFree
Nanotubes for cancer therapy and diagnostics does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Nanotubes for cancer therapy and diagnostics, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Nanotubes for cancer therapy and diagnostics will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4236813